Guided Therapeutics, Inc. announced it had executed a Clinical Trial Agreement with a prestigious academic medical institution. The clinical trial is aimed at achieving FDA approval for LuViva and is expected to involve approximately 400 women at up to three medical institutions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0873 USD | -12.70% | -12.26% | -43.13% |
1st Jan change | Capi. | |
---|---|---|
-43.13% | 4.87M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B | |
+26.76% | 32.03B |
- Stock Market
- Equities
- GTHP Stock
- News Guided Therapeutics, Inc.
- Guided Therapeutics Signs Agreement to Begin Clinical Trial for US FDA Approval